The Norepinephrine Transporter: A Novel Target for Imaging Brown Adipose Tissue

This study seeks to assess a novel imaging technique to image brown adipose tissue utilizing the norepinephrine transporter.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Brown Adipose Tissue

Age range

18 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Primary location

Yale University

New Haven, Connecticut, 06510, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age 18-30 yrs
BMI < 24 kg/m2
Caucasian

Exclusion criteria

Current neuro-psychiatric illness
substance abuse
medical or neurological illnesses likely to affect physiology or anatomy, i.e., uncontrolled hypertension, cardiovascular disorders
current pregnancy
current breast feeding
suicidal ideation or behavior
use of medications which potentially affect NET binding within 2 weeks of the PET scans.

Treatment and study plan

PET Imaging

Radiation

Primary outcomes

detection of brown adipose tissue based on PET imaging

Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

NYU Langone Health

Registry information

Important dates

Study start: 2012
Primary completion: 2013
Study completion: 2013
First posted: Jan 16, 2014
Registry last updated: Mar 30, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed